Nebivolol: a new third-generation beta-blocker agent: implications for Clinical Nurse Specialist Practice.
O'Malley
Patricia
P
Miami Valley Hospital, Dayton, Ohio, USA. pomalley@mvh.org
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001578:Benzopyrans / Q000008:administration & dosage / Q000627:therapeutic use*; D000075202:Contraindications; D004983:Ethanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000451:nursing; D000068577:Nebivolol; D009720:Nurse Clinicians
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D000068577:Nebivolol